Abstract：Objective To evaluate the symptom control and medication changes after the Stretta procedure with gastroesophageal reflux disease (GERD) during a 5-year follow-up period. Methods We evaluated GERD-health-related quality of life, satisfaction and medication use at baseline and 12 and 60 months after treatment. Results Significant changes in symptoms of GERD, the mean GERD－HRQL score was 25.6 (baseline),and 8.7(60 months,P<0.01).The mean heartburn score was 3.3 (baseline),and 1.3(60 months,P<0.05). The percentage of patients with satisfactory GERD control improved from 31.1％ at baseline to 71.6％ after treatment, and patient satisfaction improved from 1.4 at baseline to 3.8 at 60 months (P<0.01). Medication usage decreased significantly from 100% of patients on PPI therapy at baseline to 70.1% at 60 months. Conclusions The experience with Stretta procedure confirms that it is well tolerated, safe, effective, and durable in the treatment of GERD. It produces significant improvements in symptom control and and decreased medication usage during a 5-year period follow-up.
刘海峰,屈亚威,陈晓光,王伟岸,谈涛,黎君,唐红卫. 微量射频技术治疗胃食管反流病5年随访研究[J]. 武警医学, 2015, 26(12): 1193-1195.
LIU Haifeng, QU Yawei, CHEN Xiaoguang, WANG Weian, TAN Tao, LI Jun, and TANG Hongwei. 5-year follow-up study of radiofrequency energy delivery for treatment of gastroesophageal reflux disease. Med. J. Chin. Peop. Armed Poli. Forc., 2015, 26(12): 1193-1195.
Spicak J. Treatment of gastroesophageal reflux disease: endoscopic aspects[J]. Dig Dis,2007,25(3):183-187.
[1]
Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease[J]. Dig Dis,2004,22(2):108-114.
[2]
Chen D, Barber C, McLoughlin P, et al. Systematic review of endoscopic treatments for gastro-oesophageal reflux disease[J]. Br J Surg, 2009,96(2):128-136.
[4]
Jafri S M, Arora G, Triadafilopoulos G. What is left of the endoscopic antireflux devices[J]? Curr Opin Gastroenterol,2009,25(4):352-357.
[3]
Spicak J. Treatment of gastroesophageal reflux disease: endoscopic aspects[J]. Dig Dis,2007,25(3):183-187.
[5]
刘海峰.微量射频技术治疗胃食管反流病[J]. 武警医学,2010,21(6):461-466.
[4]
Jafri S M, Arora G, Triadafilopoulos G. What is left of the endoscopic antireflux devices[J]? Curr Opin Gastroenterol,2009,25(4):352-357.
[5]
刘海峰.微量射频技术治疗胃食管反流病[J]. 武警医学,2010,21(6):461-466.
[6]
Velanovich V. Comparison of symptomatic and quality of outcomes of laparoscopic versus open antireflux surgery[J].Surgery,1999,12(4):782-789.
[7]
Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease[J]. Scand J Gastroenterol,1998,33(10):1023 -1029.
[6]
Velanovich V. Comparison of symptomatic and quality of outcomes of laparoscopic versus open antireflux surgery[J].Surgery,1999,12(4):782-789.
[7]
Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease[J]. Scand J Gastroenterol,1998,33(10):1023 -1029.
[8]
Franciosa M,Mashimo H. Stretta radiofrequency treatment for GERD: a safe and effective modality [J]. Am J Gastroenterol, 2013,108(10):1654-1655.
[8]
Franciosa M,Mashimo H. Stretta radiofrequency treatment for GERD: a safe and effective modality [J]. Am J Gastroenterol, 2013,108(10):1654-1655.
[9]
Higuchi K, Fujiwara Y, Okazaki H, et al. Feasibility, safety, and efficacy of the Stretta procedure in Japanese patients with gastroesophageal reflux disease: first report from Asia[J]. J Gastroenterol, 2007,42(3):205-210.
[10]
Richards W O. Is the Stretta procedure safe and effective for the long-term control of symptoms in patients with refractory GERD?[J]. Nat Clin Pract Gastroenterol Hepatol,2007,4(12):654-655.
[9]
Higuchi K, Fujiwara Y, Okazaki H, et al. Feasibility, safety, and efficacy of the Stretta procedure in Japanese patients with gastroesophageal reflux disease: first report from Asia[J]. J Gastroenterol, 2007,42(3):205-210.
[10]
Richards W O. Is the Stretta procedure safe and effective for the long-term control of symptoms in patients with refractory GERD?[J]. Nat Clin Pract Gastroenterol Hepatol,2007,4(12):654-655.
[11]
Arts J, Bisschops R, Blondeau K, et al. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastroesophageal junction in GERD[J]. Am J Gastroenterol,2012,107(2):222-230.
[11]
Arts J, Bisschops R, Blondeau K, et al. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastroesophageal junction in GERD[J]. Am J Gastroenterol,2012,107(2):222-230.
[12]
Triadafilopoulos G, Dibaise J K, Nostrant T T, et al. Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD[J]. Gastrointest Endosc,2001,53(4):407-415.
[12]
Triadafilopoulos G, Dibaise J K, Nostrant T T, et al. Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD[J]. Gastrointest Endosc,2001,53(4):407-415.
[13]
Tam W E, Schoeman M N, Zhang Q, et al. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease[J]. Gut, 2003, 52(4):479-485.
[13]
Tam W E, Schoeman M N, Zhang Q, et al. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease[J]. Gut, 2003, 52(4):479-485.
[14]
Auyang E D , Carter P , Rauth T, et al. SAGES clinical spotlight review: endoluminal treatments for gastroesophageal reflux disease (GERD) [J]. Surg Endosc,2013,27(8):2658-2672.
[14]
Auyang E D , Carter P , Rauth T, et al. SAGES clinical spotlight review: endoluminal treatments for gastroesophageal reflux disease (GERD) [J]. Surg Endosc,2013,27(8):2658-2672.
[15]
Perry K A , Banerjee A , Melvin W S . Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis[J]. Surg Laparosc Endosc Percutan Tech,2012, 22 (4):283-288.
[15]
Perry K A , Banerjee A , Melvin W S . Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis[J]. Surg Laparosc Endosc Percutan Tech,2012, 22 (4):283-288.
[16]
Aziz A M, El-Khayat H R, Sadek A,et al. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for thetreatment of gastroesophageal reflux disease [J]. Surg Endosc,2010,24 (4):818- 825.
[16]
Aziz A M, El-Khayat H R, Sadek A,et al. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for thetreatment of gastroesophageal reflux disease [J]. Surg Endosc,2010,24 (4):818- 825.
[17]
Meier P N, Nietzschmann T, Akin I, et al. Improvement of objective GERD parameters after radiofrequency energy delivery: a European study[J]. Scand J Gastroenterol,2007, 42(8):911-916
[17]
Meier P N, Nietzschmann T, Akin I, et al. Improvement of objective GERD parameters after radiofrequency energy delivery: a European study[J]. Scand J Gastroenterol,2007, 42(8):911-916
[18]
Noar M D, Lotfi-Emran S. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure[J]. Gastrointest Endosc,2007,65(3):367-372.
[19]
Triadafilopoulos G, Dibasie J K, Nostrant T T, et al. The Stretta procedure for the treatment of GERD: 6 and 12month follow-up of the U.S.open label trial[J]. Gastrointest Endosc, 2002,55(2):149-156.
[18]
Noar M D, Lotfi-Emran S. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure[J]. Gastrointest Endosc,2007,65(3):367-372.
[19]
Triadafilopoulos G, Dibasie J K, Nostrant T T, et al. The Stretta procedure for the treatment of GERD: 6 and 12month follow-up of the U.S.open label trial[J]. Gastrointest Endosc, 2002,55(2):149-156.
2015, Vol. 26 
